Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Corren

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Journal of Asthma and Allergy|February 11, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A <i>Post Hoc</i> Analysis of the Phase 2b PATHWAY StudyClaire Emson, Jonathan Corren, Kinga Sałapa, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2004
Rhinitis therapy and the prevention of hospital care for asthma: a case-control studyJonathan Corren, Beatrice E Manning, Stephen F Thompson, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2008
Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapyJonathan Corren, Gail Shapiro, James Reimann, et al.
Clinical Therapeutics|August 19, 2007
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthmaJonathan Corren, Phillip E Korenblat, Christopher J Miller, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 29, 2021
Exacerbation-Prone Asthma: A Biological Phenotype or a Social ConstructMonica J Federico, Loren C Denlinger, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2003
Omalizumab is effective in the long-term control of severe allergic asthmaBobby Quentin Lanier, Jonathan Corren, William Lumry, et al.
Journal of Asthma and Allergy|June 10, 2022
Targeting TSLP in AsthmaJane R Parnes, Nestor A Molfino, Gene Colice, et al.
Archives of Internal Medicine|July 27, 2005
Incidence and characteristics of angioedema associated with enalaprilJohn B Kostis, Harold J Kim, James Rusnak, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Effects of omalizumab on changes in pulmonary function induced by controlled cat room challengeJonathan Corren, Robert A Wood, Deepen Patel, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointmentE Richard Stiehm, Robert L Roberts, Michael S Kaplan, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Journal of Asthma and Allergy|February 11, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A <i>Post Hoc</i> Analysis of the Phase 2b PATHWAY StudyClaire Emson, Jonathan Corren, Kinga Sałapa, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2004
Rhinitis therapy and the prevention of hospital care for asthma: a case-control studyJonathan Corren, Beatrice E Manning, Stephen F Thompson, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2008
Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapyJonathan Corren, Gail Shapiro, James Reimann, et al.
Clinical Therapeutics|August 19, 2007
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthmaJonathan Corren, Phillip E Korenblat, Christopher J Miller, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 29, 2021
Exacerbation-Prone Asthma: A Biological Phenotype or a Social ConstructMonica J Federico, Loren C Denlinger, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2003
Omalizumab is effective in the long-term control of severe allergic asthmaBobby Quentin Lanier, Jonathan Corren, William Lumry, et al.
Journal of Asthma and Allergy|June 10, 2022
Targeting TSLP in AsthmaJane R Parnes, Nestor A Molfino, Gene Colice, et al.
Archives of Internal Medicine|July 27, 2005
Incidence and characteristics of angioedema associated with enalaprilJohn B Kostis, Harold J Kim, James Rusnak, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Effects of omalizumab on changes in pulmonary function induced by controlled cat room challengeJonathan Corren, Robert A Wood, Deepen Patel, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointmentE Richard Stiehm, Robert L Roberts, Michael S Kaplan, et al.
Pageof 15